Analysis of risk factor for pediatric intensive care unit delirium in children: a case-control study

Xiao-Hua Ge1,2, Wan-Rui Wei3, Tie-Nan Feng4

  • 1School of Nursing, Naval Medical University Shanghai, China.

Insights

Pediatric intensive care unit (PICU) delirium affects 31.30% of children. Key risk factors include PRISM IV score, hypoxia, metabolic dysfunction, infection duration, and mechanical ventilation, highlighting the need for preventive measures.

Area of Science:

  • Pediatric Critical Care Medicine
  • Neuroscience
  • Intensive Care Medicine

Background:

  • Delirium is a common complication in pediatric intensive care units (PICUs).
  • Understanding the prevalence and risk factors of pediatric delirium is crucial for improving patient outcomes.

Purpose of the Study:

  • To determine the prevalence of delirium in a pediatric intensive care unit (PICU).
  • To identify associated risk factors for pediatric intensive care unit (ICU) delirium.

Main Methods:

  • A retrospective case-control study was conducted in two PICUs.
  • 639 patients aged 1 month to 7 years were enrolled from December 2018 to August 2019.
  • The Chinese version of the Cornell Assessment of Pediatric Delirium (CAPD) was used for screening, and multivariable logistic regression identified risk factors.

Main Results:

  • The prevalence of ICU pediatric delirium was 31.30%.
  • Hyperactive, hypoactive, and mixed delirium types were observed in 36%, 41%, and 23% of cases, respectively.
  • Independent risk factors identified included age, PRISM IV score, hypoxia, metabolic dysfunction, infection duration, and mechanical ventilation.

Conclusions:

  • Age, PRISM IV score, ICU length of stay, metabolic dysfunction, infection duration, hypoxia, C-reactive protein (CRP), and mechanical ventilation are independent risk factors for pediatric ICU delirium.
  • Implementing active preventive strategies is recommended to decrease the incidence of pediatric ICU delirium.
Abstract

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
434
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
37
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
35
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
38
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
31
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.8K